Publication|Videos|May 13, 2024
At DCAT With Piramal Pharma Solutions
Author(s)Piramal Pharma Solutions
Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.
At a recent Drug, Chemical & Associated Technologies (DCAT) conference, Pharmaceutical Technology spoke with Peter DeYoung, CEO, Piramal Pharma Solutions, to learn more about the company's offerings. Watch to learn more about:
- Piramal's key service offerings and integrated solutions in the areas of oncology and ADCs.
- The current operating environment for CDMOs and industry trends.
- Piramal's strategy to expand its territorial footprint in the US beyond its existing facilities.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
5